HCP Connect Contributor
Dr. Arjun Sharma
Dr. Arjun Sharma contributes cardiology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.
Recent Drug Updates
15 total
Cardiology
FDA Approves Semaglutide for HFpEF: 20% Reduction in Heart Failure Events
Semaglutide approved for HFpEF: 20% reduction in heart failure events. Key implications for clinicians.
Cardiology
Enlicitide Reduces LDL Cholesterol Significantly in Phase 3 Trial
Enlicitide reduces LDL cholesterol by 47% in HeFH patients, offering a new oral PCSK9 inhibitor option.
Cardiology
FDA Approves Semaglutide for PAD: 13% Improvement in Walking Distance in STRIDE Trial
Semaglutide approved for PAD: 13% walking distance improvement in STRIDE trial. Learn more about the implications for treatment.
Cardiology
FDA Approves Semaglutide for HFpEF: 52% Improvement in Heart Failure Symptoms
Semaglutide improves heart failure symptoms by 52% in HFpEF patients, marking a significant advancement in treatment options.
Cardiology
FDA Approves Semaglutide for Peripheral Artery Disease: STRIDE Trial Shows Improved Walking Distance
FDA approves semaglutide for peripheral artery disease: 30% improvement in walking distance in STRIDE trial.
Cardiology
FDA Approves Enlicitide for LDL Cholesterol Reduction: 30% Decrease in Phase 3 Trial
FDA approves Enlicitide for LDL cholesterol reduction: 30% decrease in Phase 3 trial results.
Cardiology
FDA Approves Empagliflozin for HFpEF: 21% Reduction in CV Events
Empagliflozin approved for HFpEF: 21% CV event reduction in EMPEROR-Preserved trial.
Health Information
Revive Dull Skin in 30 Days with Advanced Techniques
Discover how to restore your glow and boost confidence with proven skincare methods, tackling the top concern of 56% of Gen Y individuals.
Medical Research
Detect Pathogens 50% Faster with RNA Cas12a Assay
Improve disease diagnosis with a sensitive multi-guide RNA Cas12a assay, enabling early intervention and personalized treatment for tuberculosis and other poverty-linked diseases.
Health Information
Vaping vs Smoking: Impact on Dental Health
Learn how vaping and cigarette smoking affect oral hygiene, gum health, and tooth discoloration to better advise your patients on dental care.
Healthcare Business
Boost Arrhythmia Management with Data-Driven Insights
Discover how remote patient monitoring and AI can enhance symptom management, treatment effectiveness, and complication prevention in arrhythmia care.
Medical Research
Reduce Seizures 30% with Precise DBS Targeting
Discover how precise deep brain stimulation targeting can reduce seizures by 30% in patients with drug-resistant epilepsy, offering new hope for improved outcomes.
Medical Research
Gambling Harms Quadruple Youth Suicide Risk
New UK study reveals link between problem gambling and increased suicide risk in young people, with quadrupled risk four years later, informing clinicians on potential intervention...
Medical Research
Delay Hep B Shot to Age 4: Impact on Pediatric Care
Discover the potential benefits of delaying the hepatitis B vaccine until age 4 and its implications for pediatric care and vaccine schedules.
Health Information
Reduce Rheumatoid Arthritis Risk by 60%
Identify 11 key risk factors and take proactive steps to minimize your patients' likelihood of developing rheumatoid arthritis, a potentially disabling autoimmune disease.